HomeCLSD • NASDAQ
Clearside Biomedical Inc
Follow
In the news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 1.04M | 20.84% |
Operating expense | 6.97M | -10.28% |
Net income | -7.69M | 17.04% |
Net profit margin | -740.66 | 31.34% |
Earnings per share | -0.10 | 33.33% |
EBITDA | -5.86M | 16.75% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 23.59M | -18.09% |
Total assets | 29.16M | -15.28% |
Total liabilities | 63.95M | 35.29% |
Total equity | -34.79M | — |
Shares outstanding | 75.84M | — |
Price to book | -1.83 | — |
Return on assets | -47.02% | — |
Return on capital | -86.02% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -7.69M | 17.04% |
Cash from operations | -5.91M | 2.67% |
Cash from investing | 1.55M | 448.09% |
Cash from financing | 14.00K | -95.58% |
Net change in cash | -4.35M | 29.87% |
Free cash flow | -5.46M | 5.21% |
Previous close
$0.86
Day range
$0.83 - $0.89
Year range
$0.77 - $1.83
Market cap
67.12M USD
Avg Volume
247.23K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2011
Headquarters
Website
Employees
30
